Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics (RAPT) Return on Assets (2020 - 2023)

Historic Return on Assets for Therapeutics (RAPT) over the last 5 years, with Q3 2024 value amounting to 0.28%.

  • Therapeutics' Return on Assets rose 2800.0% to 0.28% in Q3 2024 from the same period last year, while for Sep 2024 it was 0.28%, marking a year-over-year increase of 2800.0%. This contributed to the annual value of 0.58% for FY2023, which is 2100.0% down from last year.
  • Therapeutics' Return on Assets amounted to 0.28% in Q3 2024, which was up 2800.0% from 0.47% recorded in Q2 2024.
  • Over the past 5 years, Therapeutics' Return on Assets peaked at 0.28% during Q3 2024, and registered a low of 0.68% during Q4 2023.
  • Over the past 5 years, Therapeutics' median Return on Assets value was 0.38% (recorded in 2023), while the average stood at 0.42%.
  • As far as peak fluctuations go, Therapeutics' Return on Assets tumbled by -3200bps in 2023, and later skyrocketed by 2800bps in 2024.
  • Therapeutics' Return on Assets (Quarter) stood at 0.43% in 2020, then rose by 22bps to 0.33% in 2021, then dropped by -8bps to 0.36% in 2022, then plummeted by -89bps to 0.68% in 2023, then surged by 59bps to 0.28% in 2024.
  • Its Return on Assets was 0.28% in Q3 2024, compared to 0.47% in Q2 2024 and 0.58% in Q1 2024.